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Background
SSALC was established to characterize HIV/AIDS-related
lymphoma and the indigenous background of malignant
lymphomas (ML) in sub-Saharan Africa. Because WHO
classified lymphoma subgroups can vary in prevalence
African, Asian or European ancestry, we surveyed lym-
phoma heterogeneity in geographically diverse East, South
and West sub-Saharan populations, particularly for HIV/
AIDS associated immunophenotypes.
Methods
A consortium of African pathologists, hematologist/oncol-
ogists and oncologic surgeons contributed ML cases and
participated in sub-grouping according to WHO classifica-
tion criteria after appropriate Institutional Review Board
(IRB) approvals, Memoranda of Understanding and Mate-
rial Transfer Agreements were obtained. Paraffin blocks
were examined for tissue morphology (H&E), immuno-
phenotype (34 antibodies IHC), EBER, kappa and lambda
light chains (CISH) and c-myc and bcl2 translocations
(FISH). HIV/AIDS diversity controls were contributed
from Europe by consortium and USA by ACSR.
Results
Consortium members contributed 46 - 368 cases each
with 1408 total cases to date: 246 diffuse large B-cell lym-
phoma (DLBCL), 296 Burkitt lymphoma, 163 Hodgkin
disease, 69 plasma cell proliferative disorders and 644
others. Aggressive DLBCL, plasmacytoma/plasmablastic
lymphoma, KSHV disease and lymphoid hyperplasia will
be highlighted.
Conclusions
Sub-Saharan Africa has a variety of ML subgroups; true
incidence altered by: 1) Aspiration vs. biopsy for diagnosis;
2) HIV status not communicated to pathologist; 3) known
HIV/AIDS patients not biopsied; 4) initial diagnosis by
morphology alone, 5) tissue preservation/processing vari-
able.. General observations: HIV/AIDS-related lymphoma
is more likely EBER+, has higher cell proliferation rates,
and unfavorable immunophenotypes; regions differ in HIV
clades with South (clade C) having the most “immunosup-
pression” associated lymphoma subgroups; East region has
more pre-T lymphoblastic lymphomas and West region
has more follicular lymphomas. Confounders: infectious
lymphadenopathies (EBV+ lymphoproliferations), undif-
ferentiated neuroblastomas, neuroectodermal tumors
(PNETs), poorly differentiated, metastatic carcinomas and
malignant melanoma (amelanotic).
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